Developing small circular mRNA vaccines for improved immunization
Small Circular mRNA Vaccines
['FUNDING_R01'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-11059920
This study is testing new small circular mRNA vaccines to see if they can provide better protection against diseases with fewer doses and side effects, making immunizations safer and more effective for everyone.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-11059920 on ClinicalTrials.gov |
What this research studies
This research focuses on creating small circular mRNA vaccines that aim to enhance the effectiveness and safety of immunizations. By utilizing advanced drug delivery systems, the study seeks to overcome the limitations of traditional vaccines, such as poor stability and weak immune responses. The approach involves synthesizing small circRNA, which is designed to be more biostable and efficiently delivered, potentially leading to better protection against diseases. Patients may benefit from more effective vaccines that require fewer doses and have fewer side effects.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals seeking vaccination against infectious diseases or cancers who may benefit from improved vaccine technology.
Not a fit: Patients who are not seeking vaccination or those with contraindications to mRNA vaccines may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer vaccines for a variety of diseases.
How similar studies have performed: Other research has shown promise in the use of mRNA vaccines, indicating that this approach could lead to significant advancements in vaccine technology.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZHU, GUIZHI — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: ZHU, GUIZHI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.